Return to Provider News

Discontinuation of Utilization Management (UM) Fax Lines

Audience: Participating Physicians, Professional Health Care Practitioners & Facilities

We are working diligently to improve our service to you by implementing the most up-to-date technology available. As part of our effort, we will provide you with real-time, streamlined tools for submitting medical records related to preauthorization requests beginning on November 1, 2021.

Effective November 1, please use one of the following options for submitting records for pre-service/prospective or concurrent review:

  • Electronic submission via our online CareAdvance Provider® tool. For urgent requests, please call Medical Intake with the case number to expedite.
  • If you are unable to register or submit via CareAdvance Provider, the Smart Data Solutions (SDS) Provider Submission Portal should be used. Additionally, you can use the SDS Provider Submission Portal to submit documents electronically via the Virtual Mailbox rather than mailing paper items to our PO Box in Eagan, MN.

It is important to know that as part of this technology upgrade, effective November 1, 2021, we can no longer accept faxes at the phone numbers listed on the reverse of this notice.

If you are not already using our automated tools, we highly encourage you to register before the UM fax lines are turned off.

Visit our website to register and learn more about these online tools. Contact your Provider Relations representative if training is needed.

Effective November 1, these fax numbers will no longer be in service:

UM Inpatient/DME


UM Outpatient


UM Skilled Nursing

1-315-731-2529 or


UM Behavioral Health


SafetyNet UM

Health Risk Assessments


Behavioral Health

1-844-878-6989 or


Care/Case Management


Long-Term Services and Supports (LTSS)


Medical Specialty Drug (MSD)


Medical Non-Urgent




Please share this information with anyone within your office or facility who should be aware.

Thank you for the quality of care and service that you provide to our valued members.

Related News
Jubilant Cadista Recalls Losartan

Cost-Share for COVID-19 Treatment Resumes January 1, 2022

Reminder: Discontinuation of Utilization Management (UM) Fax Lines

Pfizer voluntarily recalls Chantix

Information Related to NYS Executive Order #4




General Office Information

Updates and Reminders

Utilization Management

IE Browser Modal